SB Pharmco Puerto Rico

SB Pharmco Puerto Rico is a pharmaceutical manufacturing subsidiary of GSK, located in Cidra, Puerto Rico. The facility is a key site for the production of various oral solid dose medications, including treatments for depression, diabetes, and cardiovascular conditions. Historically part of SmithKline Beecham, the site became part of the GSK network following the 2000 merger between Glaxo Wellcome and SmithKline Beecham. The plant operates under stringent Good Manufacturing Practice (GMP) standards to supply global markets with high-quality pharmaceutical products. It has historically produced major brands such as Paxil, Avandia, and Coreg.